rs10246256

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2099-45850C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.705 in 152,054 control chromosomes in the GnomAD database, including 38,039 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.71 ( 38039 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.105

Publications

13 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.763 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.2099-45850C>T
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.2099-45850C>T
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000455301.2
TSL:3
n.34-45850C>T
intron
N/A
CNTNAP2
ENST00000627772.2
TSL:2
n.272-45850C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.705
AC:
107130
AN:
151936
Hom.:
38007
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.770
Gnomad AMI
AF:
0.601
Gnomad AMR
AF:
0.669
Gnomad ASJ
AF:
0.816
Gnomad EAS
AF:
0.633
Gnomad SAS
AF:
0.733
Gnomad FIN
AF:
0.587
Gnomad MID
AF:
0.807
Gnomad NFE
AF:
0.690
Gnomad OTH
AF:
0.734
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.705
AC:
107210
AN:
152054
Hom.:
38039
Cov.:
32
AF XY:
0.698
AC XY:
51899
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.770
AC:
31926
AN:
41470
American (AMR)
AF:
0.668
AC:
10200
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.816
AC:
2833
AN:
3470
East Asian (EAS)
AF:
0.633
AC:
3269
AN:
5168
South Asian (SAS)
AF:
0.732
AC:
3518
AN:
4808
European-Finnish (FIN)
AF:
0.587
AC:
6204
AN:
10568
Middle Eastern (MID)
AF:
0.799
AC:
235
AN:
294
European-Non Finnish (NFE)
AF:
0.690
AC:
46925
AN:
67988
Other (OTH)
AF:
0.736
AC:
1554
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1612
3224
4837
6449
8061
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
834
1668
2502
3336
4170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.680
Hom.:
18415
Bravo
AF:
0.714
Asia WGS
AF:
0.696
AC:
2424
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
5.1
DANN
Benign
0.54
PhyloP100
0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10246256; hg19: chr7-147554807; API